USPTO Examiner GREIG THOMAS W - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18737913EYE TREATMENT APPARATUS AND METHOD WITH INDEPENDENT PRESSURE SOURCESJune 2024November 2025Allow1720YesNo
18665969SYSTEMS AND METHODS FOR TREATING FLUID STASISMay 2024September 2024Allow410NoNo
18625281RESPIRATORY PRESSURE THERAPY DEVICEApril 2024July 2025Allow1610NoNo
18539372CONTROL SYSTEM FOR PORTABLE OXYGEN CONCENTRATORDecember 2023March 2026Allow2710YesNo
18482405PATIENT INTERFACE AND ASPECTS THEREOFOctober 2023April 2025Allow1810NoNo
18448461POWERING BREATHING APPARATUSAugust 2023December 2025Allow2820YesNo
18198698DRY POWDER INHALERMay 2023March 2025Allow2220YesNo
18197703POSITIVE PRESSURE VENTILATION APPARATUS AND POSITIVE PRESSURE MASKMay 2023September 2024Allow1620NoNo
18310152START-UP PROTOCOLS FOR NITRIC OXIDE DELIVERY DEVICEMay 2023October 2025Allow3030NoNo
18138607DEVICES AND METHODS FOR ENCOURAGING NASAL BREATHINGApril 2023May 2025Allow2520NoNo
18296729METHOD OF DETECTING ERRORS IN THE CONNECTIONS IN A HUMIDIFICATION SYSTEMApril 2023September 2024Allow1800NoNo
18128539OXYGEN MASKSMarch 2023March 2026Abandon3530NoNo
18100357PORTABLE ELECTRONIC VAPORIZER HAVING REMOVABLY ATTACHABLE VAPORIZATION MODULE, REMOVABLY ATTACHABLE BASE PORTION, AND METHODJanuary 2023June 2023Allow400NoNo
18069359POSTOPERATIVE PLASTIC SURGERY AESTHETIC LYMPHATIC DRAINAGE METHODDecember 2022September 2025Allow3300YesNo
18065794VAGINAL HEALTH DIAGNOSTICSDecember 2022March 2024Allow1510NoNo
18051894SEAL FORMING PORTION, PAD AND CUSHION FOR A PATIENT INTERFACE AND METHOD OF MANUFACTURINGNovember 2022March 2024Allow1610NoNo
17963309SYSTEM AND METHOD FOR PROVIDING ENHANCED PAP METRICSOctober 2022August 2024Allow2220NoNo
17938588INSTRUMENT FOR ASSISTED SOFT TISSUE MOBILIZATIONOctober 2022October 2025Allow3610NoNo
17937037HOT AIR RESPIRATORY THERAPY SYSTEMS AND METHODSSeptember 2022January 2026Abandon3910NoNo
17908753A PORTABLE AUTOMATED LIFE-SAVING SYSTEM WITH DYNAMIC ADAPTATIONSeptember 2022January 2026Allow4101NoNo
17887324APPARATUS FOR USE IN A RESPIRATORY SUPPORT SYSTEMAugust 2022September 2024Allow2510YesNo
17858842ADAPTOR FOR RESPIRATORY ASSISTANCE SYSTEMSJuly 2022January 2025Allow3120NoNo
17808471NASAL CANNULAJune 2022September 2024Allow2730YesNo
17786022PORTABLE RESPIRATORY DEVICE HAVING POWER SUPPLY VIA POWER GRID AND ELECTRICITY STORAGE DEVICEJune 2022February 2026Allow4410NoNo
17839583HEATING APPARATUS FOR REMOVING MUCUSJune 2022August 2025Allow3810NoNo
17784769HUMIDIFICATION DEVICE FOR A POSITIVE AIRWAY PRESSURE BREATHING APPARATUSJune 2022June 2025Allow3600YesNo
17826299Portable Pain Relief Device Utilizing Polymer Based Materials or a Combination of EL Material and Polymer Based MaterialsMay 2022April 2024Abandon2310NoNo
17739244PATIENT INTERFACEMay 2022May 2024Allow2410YesNo
17771663STIMULATOR SUBSTRATE DEVICE AND DEVICE FOR STIMULATING NERVE CELLSApril 2022October 2025Abandon4210NoNo
17724709VEST APPARATUS FOR PROVIDING VIBRATIONAL STIMULUSApril 2022January 2025Abandon3340YesNo
17695785Positive Pressure Respirator AssemblyMarch 2022March 2026Abandon4820YesNo
17678771POSITIVE PRESSURE VENTILATION APPARATUS AND POSITIVE PRESSURE MASKFebruary 2022March 2023Allow1310YesNo
17675068APPARATUS AND METHOD FOR AN ENDOTRACHEAL TUBE HOLDERFebruary 2022August 2025Allow4210NoNo
17672104USER INTERFACE FOR SUPPLYING GASES TO AN AIRWAYFebruary 2022August 2024Allow3020NoNo
17650498OXYGEN THERAPY ADMINISTRATION METHODS AND RELATED APPARATUSFebruary 2022September 2023Allow1910NoNo
17539721PATIENT INTERFACE AND ASPECTS THEREOFDecember 2021September 2024Allow3420NoNo
17530558Hood For Powered Air Purifying RespiratorNovember 2021July 2025Abandon4410NoNo
17512434EXPANDABLE ENDOTRACHEAL TUBEOctober 2021May 2023Allow1831YesNo
17270717THERAPEUTIC TREATMENT KITOctober 2021May 2025Allow5100YesNo
17437508AN IMPROVED HEATER PLATESeptember 2021January 2025Allow4110NoNo
17437197LUMINOUS RESPIRATORY VENTILATION DEVICESeptember 2021March 2025Allow4210NoNo
17437376SYSTEMS AND METHODS FOR CONTROLLING HUMIDITY OUTPUT IN A HUMIDIFIERSeptember 2021April 2025Allow4300YesNo
17437113NOISE REDUCTION DEVICE FOR RESPIRATORY APPARATUSSeptember 2021August 2025Allow4720NoNo
17437215RESPIRATORY APPARATUS WITH NOISE-DAMPING MEMBERSeptember 2021March 2025Allow4210NoNo
17435443DEVICE FOR SELECTIVE REGIONALIZATION OF PULMONARY AERATION TO THE POSTEROLATERAL PART OF THE LUNGSSeptember 2021September 2024Allow3710NoNo
17435329SYSTEMS AND METHODS FOR SUSTAINED BREATH DELIVERY TO NEONATESAugust 2021September 2024Allow3710NoNo
17462264CPAP APPARATUSAugust 2021February 2026Allow5320NoYes
17459016VENTILATOR ASSEMBLY AND MIXING SYSTEM THEREFORAugust 2021July 2025Abandon4720NoNo
17458649WIRELESS RECHARGEABLE AND PORTABLE ANTI-MICROBIAL RESPIRATORAugust 2021April 2024Allow3200YesNo
17458710Intubation ApparatusAugust 2021August 2024Allow3610NoNo
17412738METHOD OF FORMING AEROSOL-GENERATING ARTICLE WITH RETENTION MEDIUMAugust 2021July 2025Allow4740YesNo
17405544Ventilation Devices and Systems and Methods of Using SameAugust 2021January 2025Allow4120YesNo
17424127MASSAGE HEAD UNIT, VIBRATION ASSEMBLY AND SMART WEARABLE DEVICEJuly 2021July 2024Allow3610NoNo
17378586PATIENT INTERFACE AND ASPECTS THEREOFJuly 2021July 2023Allow2410NoNo
17423807EXOSKELETON ROBOT FOR MOTOR REHABILITATION OF THE HAND AND WRISTJuly 2021August 2024Allow3710YesNo
17422513DEVICE FOR INHALING POWDER-TYPE SUBSTANCESJuly 2021January 2025Allow4200YesNo
17418079THERMAL AND VIBROTACTILE HAPTIC ACTUATORSJune 2021July 2025Allow4930YesNo
17298031MULTIMODAL HUMAN-ROBOT INTERACTION SYSTEM FOR UPPER LIMB REHABILITATIONMay 2021August 2024Allow3810NoNo
17321750ADJUSTABLE HEADGEAR TUBING FOR A PATIENT INTERFACEMay 2021June 2023Allow2510NoNo
17316010PATIENT INTERFACE WITH BLOWOUT PREVENTION FOR SEAL-FORMING PORTIONMay 2021March 2023Allow2200YesNo
17245887THERAPEUTIC DEVICES AND METHODS FOR APPLYING COMPRESSION, VIBRATION, AND/OR HEAT TO AN INDIVIDUALApril 2021June 2025Abandon4920NoNo
17290159MASSAGE ASSEMBLY, HUMAN BODY MASSAGE DEVICE, AND OPERATION METHOD THEREOFApril 2021June 2025Allow4910YesNo
17239880DEVICES AND METHODS FOR TREATING LUNG DISEASESApril 2021January 2025Allow4520NoNo
17223873INHALERApril 2021March 2024Allow3510NoNo
17222700DETERMINING CHEST COMPRESSION DEPTH USING IMPEDANCEApril 2021February 2025Allow4630YesNo
17282384DEVICES AND METHODS FOR TREATING A BREATHING-RELATED SLEEP DISORDER, METHODS OF USE AND CONTROL PROCESSES FOR SUCH A DEVICEApril 2021October 2025Allow5530YesNo
17217010AIR FILTRATION AND USER MOVEMENT MONITORING DEVICESMarch 2021April 2024Abandon3710NoNo
17194602METHODS AND APPARATUS FOR VENTILATORY TREATMENT OF RESPIRATORY DISORDERSMarch 2021January 2024Allow3420NoNo
17193034FILTER ASSEMBLY AND AIRWAY PRESSURE SUPPORT SYSTEM EMPLOYING SAMEMarch 2021September 2023Allow3110NoNo
17174149DRY POWDER INHALERFebruary 2021July 2023Abandon2910NoNo
17137645Portable Pain Relief Device Utilizing Polymer Based Materials or a Combination of EL Material and Polymer Based MaterialsDecember 2020January 2022Allow1320NoNo
17130094EYE TREATMENT APPARATUS AND METHOD WITH INDEPENDENT PRESSURE SOURCESDecember 2020March 2024Allow3910YesNo
17121115MASK APPARATUSDecember 2020March 2024Allow4010NoNo
17121056MASK APPARATUSDecember 2020April 2024Allow4010NoNo
17111801MANUFACTURED TO SHAPE HEADGEAR AND MASKSDecember 2020July 2022Allow2031YesNo
17063380OXYGEN THERAPY ADMINISTRATION METHODS AND RELATED APPARATUSOctober 2020January 2022Allow1630YesNo
17060970REUSABLE RESPIRATORY PROTECTION DEVICEOctober 2020January 2023Allow2700YesNo
17017620METHODS AND DEVICES FOR DETERMINING A POSITION OF AN ENDOTRACHEAL TUBESeptember 2020February 2024Allow4120NoNo
17015451DETECTING AND TREATING COPD-OSA OVERLAP SYNDROMESeptember 2020October 2023Allow3710NoNo
16989950CONTROL SYSTEM FOR PORTABLE OXYGEN CONCENTRATORAugust 2020September 2023Allow3720YesNo
16984875DRY POWDER INHALERAugust 2020December 2022Allow2900YesNo
16936831ROTATABLE SURGICAL TABLEJuly 2020August 2023Allow3710NoNo
16895722RESPIRATORY PRESSURE THERAPY DEVICEJune 2020March 2024Allow4520NoNo
16765635MEDICAL DEVICE LOCATION TRACKINGMay 2020January 2025Abandon5630NoNo
16763555VAPORIZER SYSTEMMay 2020October 2023Abandon4110NoNo
16864777BREATHING AIR SUPPLY SYSTEM WITH CONTACTLESS VITAL PARAMETER SENSOR MEASURINGMay 2020February 2023Allow3420NoNo
16854669INTERACTIVE APPARATUS AND METHOD FOR REAL-TIME PROFILING OF INHALATION EFFORTSApril 2020August 2023Allow4020NoNo
16852993REUSABLE RESPIRATORY PROTECTION DEVICEApril 2020September 2020Allow410YesNo
16849377BRONCHOSCOPEApril 2020October 2022Abandon3010NoNo
16849412BRONCHOSCOPEApril 2020April 2022Allow2400NoNo
16839014POSITIVE PRESSURE VENTILATION APPARATUS AND POSITIVE PRESSURE MASKApril 2020June 2022Abandon2640YesNo
16808884NASAL CANNULA WITHOUT NOSTRIL PRONGSMarch 2020February 2023Allow3530YesNo
16779693HYDROGEN SUPPLY APPARATUS AND HYDROGEN SUPPLY SYSTEMFebruary 2020May 2023Allow4010YesNo
16776318VAGINAL HEALTH DIAGNOSTICSJanuary 2020September 2022Allow3220YesNo
16628996SYSTEM FOR ASSISTING BREATHING AND A PATIENT SET THEREFORJanuary 2020February 2023Allow3720NoNo
16726087AIRWAY INHALANT NEBULIZER CARTRIDGEDecember 2019May 2024Abandon5340NoNo
16623428A SYSTEM FOR HUMIDIFICATION OF A PRESSURIZED FLOW OF BREATHABLE GAS DELIVERED TO A PATIENTDecember 2019December 2022Allow3630YesNo
16700833AIRWAY INHALANT NEBULIZER DEVICEDecember 2019March 2023Allow4010NoNo
16617388POWERING BREATHING APPARATUSNovember 2019May 2023Allow4220NoNo
16693936METHODS, SYSTEMS, AND DEVICES FOR CONTROLLING MECHANICAL VENTILATIONNovember 2019January 2023Allow3800YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner GREIG, THOMAS W.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
20.7%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
3
Allowed After Appeal Filing
1
(33.3%)
Not Allowed After Appeal Filing
2
(66.7%)
Filing Benefit Percentile
55.5%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 33.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner GREIG, THOMAS W - Prosecution Strategy Guide

Executive Summary

Examiner GREIG, THOMAS W works in Art Unit 3785 and has examined 158 patent applications in our dataset. With an allowance rate of 75.9%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 38 months.

Allowance Patterns

Examiner GREIG, THOMAS W's allowance rate of 75.9% places them in the 42% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by GREIG, THOMAS W receive 1.77 office actions before reaching final disposition. This places the examiner in the 39% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GREIG, THOMAS W is 38 months. This places the examiner in the 31% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +30.9% benefit to allowance rate for applications examined by GREIG, THOMAS W. This interview benefit is in the 79% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 36.3% of applications are subsequently allowed. This success rate is in the 82% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 36.5% of cases where such amendments are filed. This entry rate is in the 55% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 44.4% are granted (fully or in part). This grant rate is in the 38% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 1.7% of allowed cases (in the 66% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • RCEs are effective: This examiner has a high allowance rate after RCE compared to others. If you receive a final rejection and have substantive amendments or arguments, an RCE is likely to be successful.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.